Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Dec;42(3):1187–1190. doi: 10.1128/iai.42.3.1187-1190.1983

Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

M L Tamplin, S Specter, G E Rodrick, H Friedman
PMCID: PMC264424  PMID: 6642665

Abstract

The ability of Vibrio vulnificus to resist human serum bactericidal action and to activate human complement was compared with similar cultures of Vibrio cholerae and Vibrio parahaemolyticus. Both V. vulnificus and V. parahaemolyticus had similar survival rates in sera and were much more resistant to killing than was V. cholerae. In contrast, V. vulnificus activated significantly less serum complement than did V. cholerae and V. parahaemolyticus. The relative ability of V. vulnificus to survive in serum and activate less complement than other Vibrio spp. tested may be related to its ability to cause chronic tissue infections and septicemias.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blake P. A., Merson M. H., Weaver R. E., Hollis D. G., Heublein P. C. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med. 1979 Jan 4;300(1):1–5. doi: 10.1056/NEJM197901043000101. [DOI] [PubMed] [Google Scholar]
  2. Blake P. A., Weaver R. E., Hollis D. G. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol. 1980;34:341–367. doi: 10.1146/annurev.mi.34.100180.002013. [DOI] [PubMed] [Google Scholar]
  3. Bowdre J. H., Poole M. D., Oliver J. D. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun. 1981 Jun;32(3):1193–1199. doi: 10.1128/iai.32.3.1193-1199.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carruthers M. M., Kabat W. J. Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serum. Infect Immun. 1981 May;32(2):964–966. doi: 10.1128/iai.32.2.964-966.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Conn H. O., Fessel J. M. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) 1971 May;50(3):161–197. doi: 10.1097/00005792-197105000-00002. [DOI] [PubMed] [Google Scholar]
  6. Ellington E. P., Wood J. G., Hill E. O. Disease caused by a marine vibrio--Vibrio vulnificus. N Engl J Med. 1982 Dec 23;307(26):1642–1642. doi: 10.1056/NEJM198212233072609. [DOI] [PubMed] [Google Scholar]
  7. Fernandez C. R., Pankey G. A. Tissue invasion by unnamed marine vibrios. JAMA. 1975 Sep 15;233(11):1173–1176. [PubMed] [Google Scholar]
  8. Fierer J., Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest. 1979 May;63(5):912–921. doi: 10.1172/JCI109391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gerding D. N., Khan M. Y., Ewing J. W., Hall W. H. Pasteurella multocida peritonitis in hepatic cirrhosis with ascites. Gastroenterology. 1976 Mar;70(3):413–415. [PubMed] [Google Scholar]
  10. Hollis D. G., Weaver R. E., Baker C. N., Thornsberry C. Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol. 1976 Apr;3(4):425–431. doi: 10.1128/jcm.3.4.425-431.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jones E. A., Sherlock S., Crowley N. Bacteraemia in association with hepatocellular and hepatobiliary disease. Postgrad Med J. 1967 Mar;43(Suppl):7–11. [PubMed] [Google Scholar]
  12. Kreger A., Lockwood D. Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect Immun. 1981 Aug;33(2):583–590. doi: 10.1128/iai.33.2.583-590.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lay W. H., Nussenzweig V. Receptors for complement of leukocytes. J Exp Med. 1968 Nov 1;128(5):991–1009. doi: 10.1084/jem.128.5.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Liu Y. K. Phagocytic capacity of reticuloendothelial system in alcoholics. J Reticuloendothel Soc. 1979 Jun;25(6):605–613. [PubMed] [Google Scholar]
  15. Matsuo T., Kohno S., Ikeda T., Saruwatari K., Ninomiya H. Fulminating lactose-positive Vibrio septicemia. Acta Pathol Jpn. 1978 Nov;28(6):937–948. doi: 10.1111/j.1440-1827.1978.tb01282.x. [DOI] [PubMed] [Google Scholar]
  16. Mertens A., Nagler J., Hansen W., Gepts-Friedenreich E. Halophilic, lactose-positive Vibrio in a case of fatal septicemia. J Clin Microbiol. 1979 Feb;9(2):233–235. doi: 10.1128/jcm.9.2.233-235.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meshulam T., Verbrugh H., Verhoef J. Serum-induced lysis of Pseudomonas aeruginosa. Eur J Clin Microbiol. 1982 Feb;1(1):1–6. doi: 10.1007/BF02014132. [DOI] [PubMed] [Google Scholar]
  18. Morrison D. C., Kline L. F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977 Jan;118(1):362–368. [PubMed] [Google Scholar]
  19. Muller-Eberhard H. J., Nilsson U. R., Dalmasso A. P., Polley M. J., Calcott M. A. A molecular concept of immune cytolysis. Arch Pathol. 1966 Sep;82(3):205–217. [PubMed] [Google Scholar]
  20. Poole M. D., Oliver J. D. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun. 1978 Apr;20(1):126–129. doi: 10.1128/iai.20.1.126-129.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Smith G. C., Merkel J. R. Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness. Infect Immun. 1982 Mar;35(3):1155–1156. doi: 10.1128/iai.35.3.1155-1156.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TISDALE W. A. Spontaneous colon bacillus bacteremia in Laennec's cirrhosis. Gastroenterology. 1961 Jan;40:141–148. [PubMed] [Google Scholar]
  23. Tamplin M., Rodrick G. E., Blake N. J., Cuba T. Isolation and characterization of Vibrio vulnificus from two Florida estuaries. Appl Environ Microbiol. 1982 Dec;44(6):1466–1470. doi: 10.1128/aem.44.6.1466-1470.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tarao K., So K., Moroi T., Ikeuchi T., Suyama T. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance. Gastroenterology. 1977 Sep;73(3):539–542. [PubMed] [Google Scholar]
  25. Targan S. R., Chow A. W., Guze L. B. Spontaneous peritonitis of cirrhosis due to Campylobacter fetus. Gastroenterology. 1976 Aug;71(2):311–313. [PubMed] [Google Scholar]
  26. Tofte R. W., Peterson P. K., Kim Y., Quie P. G. Influence of serum concentration on opsonization by the classical and alternative complement pathways. Infect Immun. 1980 Feb;27(2):693–696. doi: 10.1128/iai.27.2.693-696.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wright A. C., Simpson L. M., Oliver J. D. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun. 1981 Nov;34(2):503–507. doi: 10.1128/iai.34.2.503-507.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES